The ACC has named Matthias Nahrendorf, MD, PhD, as the new Editor-in-Chief of JACC: Basic to Translational Science. Nahrendorf brings to the journal a distinguished career in cardiovascular research, imaging and immunology, along with a commitment to interdisciplinary collaboration and scientific excellence.

As Editor-in-Chief of JACC: Basic to Translational Science, Nahrendorf said he aims to further the journal's mission of publishing cutting-edge research with high visibility, quality and impact.

"I am honored to take on this role and help amplify the voices of investigators advancing the frontiers of our field," Nahrendorf said. "I look forward to working with the editorial team and contributors to advance translational cardiovascular research."

Nahrendorf currently serves as the director of the Gordon Center for Medical Imaging at Massachusetts General Hospital (MGH), where he leads efforts to integrate imaging technologies with cardiovascular and immunological research, and as a professor of radiology at Harvard Medical School. His laboratory at the MGH Center for Systems Biology focuses on the role of immunity in cardiovascular health and disease.

Nahrendorf has authored over 300 peer-reviewed publications, reflecting the significant impact of his work in the fields of cardio-immunology, heart failure, vascular biology and hematology. His contributions have been recognized with numerous awards, including the MGH Research Scholar Award (2014–2019), the Basic Research Award from the German Society of Cardiology (2015), and the MGH Martin Prize (2019).

His research has significantly advanced the understanding of how immune responses contribute to cardiovascular pathology. By pioneering advanced imaging techniques such as MRI, nuclear scans and optical imaging, Nahrendorf has opened new, non-invasive ways to understand how heart disease develops at the cellular level.

In recognition of his contributions, Nahrendorf has also been appointed to prestigious positions such as the NHLBI Board of External Experts and has served as chair of the Atherosclerosis Gordon Research Conference.

"Dr. Nahrendorf, as an esteemed scientist, energetic leader, and creative visionary, is the ideal person to lead JACC: Basic to Translational Science into its next phase," said JACC Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC. "Building on the outstanding work of our founding editor, Dr. Douglas Mann, he brings a bold vision for accelerating discovery and impact in translational cardiovascular research. We're thrilled to welcome him to the JACC leadership team."